Reporter system for radionuclide imaging
US-2023211023-A1 · Jul 6, 2023 · US
This page is not indexed by search engines while we improve data quality.
Univ Erasmus Med Ct Rotterdam — Cross-Sectional Technologies
Univ Erasmus Med Ct Rotterdam holds 14 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Univ Erasmus Med Ct Rotterdam |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 14 |
| Recent patents in slice | 1 |
| First year | 2017 |
| Last year | 2023 |
Representative patents
Notable publications linking Univ Erasmus Med Ct Rotterdam to Cross-Sectional Technologies.
Geminoid lipopeptide compounds and their uses
US-2022017572-A1 · Jan 20, 2022 · US
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
US-11220718-B2 · Jan 11, 2022 · US
Treatments and biomarkers for the prognosis of zika virus infection
US-2021148936-A1 · May 20, 2021 · US
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
US-2020399718-A1 · Dec 24, 2020 · US
Recent filings
Latest patents from Univ Erasmus Med Ct Rotterdam in Cross-Sectional Technologies.
Reporter system for radionuclide imaging
US-2023211023-A1 · Jul 6, 2023 · US
Geminoid lipopeptide compounds and their uses
US-2022017572-A1 · Jan 20, 2022 · US
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
US-11220718-B2 · Jan 11, 2022 · US
Treatments and biomarkers for the prognosis of zika virus infection
US-2021148936-A1 · May 20, 2021 · US
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
US-2020399718-A1 · Dec 24, 2020 · US
Related pages
Navigate to parent entity pages.